Archive - September 2018
Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline
Boehringer bolts on another immuno-oncology company
Boehringer buys cancer immunotherapy developer
Shire’s bleeding disorder drug approved in Europe
BMS psoriasis drug hits the mark in phase II
Boehringer buys ViraTherapeutics
A&E attendances in England leap 22% in a decade
Gilead, Precision to co-develop hepatitis B therapies